Business Description
Tonix Pharmaceuticals Holding Corp
NAICS : 325412
SIC : 2834
ISIN : US8902604094
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.54 | |||||
Equity-to-Asset | 0.68 | |||||
Debt-to-Equity | 0.09 | |||||
Debt-to-EBITDA | -0.09 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -7.48 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 60.3 | |||||
3-Year EPS without NRI Growth Rate | 60.4 | |||||
3-Year FCF Growth Rate | 62.3 | |||||
3-Year Book Growth Rate | -72.3 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
12-1 Month Momentum % | -0.9 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.53 | |||||
Quick Ratio | 1.78 | |||||
Cash Ratio | 1.32 | |||||
Days Inventory | 1056.38 | |||||
Days Sales Outstanding | 73.39 | |||||
Days Payable | 544.12 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -284.6 | |||||
Shareholder Yield % | -50.17 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 38.97 | |||||
Operating Margin % | -1523.94 | |||||
Net Margin % | -1501.78 | |||||
FCF Margin % | -1416.87 | |||||
ROE % | -78.88 | |||||
ROA % | -67.96 | |||||
ROIC % | -107.65 | |||||
ROC (Joel Greenblatt) % | -119.81 | |||||
ROCE % | -76.68 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.48 | |||||
PB Ratio | 0.09 | |||||
Price-to-Tangible-Book | 0.1 | |||||
EV-to-Revenue | 0.02 | |||||
FCF Yield % | -717.2 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Tonix Pharmaceuticals Holding Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 7.203 | ||
EPS (TTM) (€) | -7.651 | ||
Beta | 3.59 | ||
Volatility % | 25.49 | ||
14-Day RSI | 0 | ||
14-Day ATR (€) | 0.000007 | ||
20-Day SMA (€) | 2.82 | ||
12-1 Month Momentum % | -0.9 | ||
52-Week Range (€) | 2.415 - 2.8725 | ||
Shares Outstanding (Mil) | 95.54 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Tonix Pharmaceuticals Holding Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Tonix Pharmaceuticals Holding Corp Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Tonix Pharmaceuticals Holding Corp Frequently Asked Questions
What is Tonix Pharmaceuticals Holding Corp(STU:TPM0)'s stock price today?
When is next earnings date of Tonix Pharmaceuticals Holding Corp(STU:TPM0)?
Does Tonix Pharmaceuticals Holding Corp(STU:TPM0) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |